Skip to main content

Table 3 Top five HLA-DR, HLA-DQ, and HLA-DP epitopes

From: In silico vaccine design and epitope mapping of New Delhi metallo-beta-lactamase (NDM): an immunoinformatics approach

 

Rank

Location

Epitope

Antigenicity (probability)

HLA-DR

1

201–2015

KASMIVMSHSAPDSR

Non-antigen (66%)

 

2

200–214

PKASMIVMSHSAPDS

Antigen (66%)

 

3

203–217

SMIVMSHSAPDSRAA

Non-antigen (66%)

 

4

202–216

ASMIVMSHSAPDSRA

Non-antigen (66%)

 

5

4–18

RFGDLVFRQLAPNVW

Non-antigen (66%)

HLA-DQ

1

186–200

EHYAASARAFGAAFP

Antigen (100%)

 

2

91–105

LHAAGIATYANALSN

Antigen (66%)

 

3

89–103

DALHAAGIATYANAL

Antigen (66%)

 

4

185–199

TEHYAASARAFGAAF

Antigen (100%)

 

5

90–104

ALHAAGIATYANALS

Antigen (100%)

HLA-DP

1

3–17

QRFGDLVFRQLAPNV

Non-antigen (66%)

 

2

15–29

PNVWQHTSYLDMPGF

Non-antigen (66%)

 

3

1–15

GDQRFGDLVFRQLAP

Non-antigen (66%)

 

4

2–16

DQRFGDLVFRQLAPN

Antigen (66%)

 

5

16–30

NVWQHTSYLDMPGFG

Antigen (66%)